OTCM
KURRY
Market cap3.14bUSD
Jul 09, Last price
30.96USD
1D
0.00%
1Q
-5.21%
Jan 2017
-30.72%
Name
Kuraray Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kuraray Co., Ltd. operates as a global enterprise, manufacturing and distributing a diverse array of products, encompassing various resins, chemicals, fibers, activated carbon, and sophisticated membrane systems. Within its operational framework, the Vinyl Acetate segment is dedicated to creating and commercializing functional resins and films, notable examples being PVA, PVB, and EVAL. Another key area, the Isoprene segment, is responsible for developing and marketing SEPTON thermoplastic elastomers, along with other isoprene-derived goods and GENESTAR. Furthermore, Kuraray's Functional Materials division produces and supplies methacrylic resins, medical-grade products, and carbon materials. The Fibers and Textiles segment oversees the production and sale of synthetic fibers, a range of textiles, the distinguished CLARINO man-made leather, non-woven fabrics, and similar items. Completing its portfolio, the Trading segment is primarily involved in processing and distributing synthetic fibers and artificial leathers. The company, which has been in operation since its founding in 1926, maintains its headquarters in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||